Ftse Mib
34.099,67
-0,80%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
98.118,99
1,26%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX iBio Inc (IBIO) iBio Inc (IBIO) Notizie

iBio Inc

IBIO
2,50
0,08 (3,31%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:39:37
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/1/202523:19EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
02/1/202513:36EDGAR2Form 8-K - Current report
02/1/202513:00GLOBEiBio Expands Cardiometabolic and Obesity Program with..
09/12/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202423:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/11/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202414:30EDGAR2Form 8-K - Current report
25/11/202414:00GLOBEiBio Strengthens Board with Appointment of Two New..
15/11/202402:47EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
14/11/202422:48EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:06EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEiBio Reports Fiscal First Quarter 2025 Financial Results
23/10/202415:12EDGAR2Form 8-K - Current report
10/10/202422:10EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202414:00GLOBEiBio and AstralBio Provide Update on Myostatin Program for..
24/9/202422:11EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
20/9/202422:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/9/202422:07EDGAR2Form 8-K - Current report
20/9/202422:05GLOBEiBio Reports Fiscal Year 2024 Financial Results and Provides..
03/9/202413:00GLOBEiBio to Participate in Upcoming Investor Conferences
12/8/202422:30GLOBEiBio Expands Executive Leadership Team with Appointment of..
06/8/202423:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/7/202415:03EDGAR2Form 8-K - Current report
25/7/202423:05EDGAR2Form S-3/A - Registration statement under Securities Act of..
09/7/202422:02EDGAR2Form 8-K - Current report
05/6/202422:10EDGAR2Form 8-K - Current report
03/6/202422:08EDGAR2Form 8-K - Current report
03/6/202413:00GLOBEiBio Closes Sale of Manufacturing Facility in Texas
20/5/202412:55EDGAR2Form 8-K - Current report
13/5/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202422:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:08EDGAR2Form 8-K - Current report
13/5/202422:05GLOBEiBio Reports Fiscal Third Quarter 2024 Financial Results and..
27/3/202412:00GLOBEiBio and AstralBio Announce Transformative AI drug discovery..
27/3/202400:35GLOBEiBio Announces $15.0 Million Private Placement
26/2/202413:59EDGAR2Form 8-K - Current report
26/2/202413:45GLOBEiBio Announces Sale of Preclinical PD-1 Agonist Antibody..
21/2/202422:55EDGAR2Form 8-K - Current report
19/1/202422:36EDGAR2Form 8-K - Current report
16/1/202414:15GLOBEiBio Announces Participation in 23rd Annual PepTalk..
10/1/202419:24EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202422:30EDGAR2Form 8-K - Current report
04/1/202414:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
Apertura: 2,46 Min: 2,35 Max: 2,4747
Chiusura: 2,42

La tua Cronologia

AMEX
IBIO
iBio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network